We went on to test whether the modifying effect of ApoE in FTD-tau might relate to the presence of Aβ copathology without meeting criteria for a formal pathological diagnosis of AD in 139 cases with available neuropathological data. This evidence concerns the gene MAPT and Alzheimer disease.